Back

Autoimmune-like CD8⁺ T Cell Responses Drive Atherosclerotic Plaque Instability and Predict Cardiovascular Events

Noonan, J.; Borcherding, N.; van der Laan, S. W.; Gherardin, N. A.; Morsy, M. I.; Gray, J. I.; Domke, L. M.; Watson, A.; Huang, A.; Barbaro-Wahl, A.; Prijaya, S. A.; Michla, M.; Elahi, Z.; Huang, Y.; Dayawansa, N. H.; Bongcaron, V.; Walsh, A.; Sharma, P.; Maluenda, A.; Kanellakis, P.; Farrugia, G. E.; Lee, M.-K. S.; Murphy, A. J.; Hsu, I. K.; Pinto, A. R.; Johnson, C. J.; Chen, Y.-C.; Eddy, E.; Le Page, M.; Lovelock, T. M.; Wang, J.; Bourke, M.; Rahman, Z.; Varley, V.; Kilby, J.; Zentilin, L.; Giacca, M.; McFadyen, J. D.; Mokry, M. M.; Pasterkamp, G.; Wang, X.; Martelotto, L.; Hill, D. L.; Ott

2026-04-29 immunology
10.64898/2026.04.26.720043 bioRxiv
Show abstract

Background and aimsAtherosclerotic plaque rupture is a major cause of myocardial infarction and stroke. However, the precise drivers of plaque destabilisation remain elusive. We hypothesised that antigen-driven, autoimmune-like T cell responses are central to the destabilisation and rupture of atherosclerotic plaques. MethodsTo dissect T cell responses specifically in unstable compared to stable plaques, we leveraged near-infrared autofluorescence (NIRAF) imaging-guided dissection of human carotid plaques. We also used our tandem stenosis model reflecting plaque instability as seen in patients to differentiate between unstable and stable plaques in mice. To explore T cell involvement, we studied T cell differentiation states and T cell receptor (TCR) repertoires by single-cell multi-omics. Then, testing if antigen-driven CD8+ T cell responses drive plaque instability in mice, we applied a combination of AAV8-PCSK9-induced atherosclerosis, tandem stenosis and TCR transgenic mice. Finally, we leveraged data from the AtheroExpress Biobank Study to link T cell immunity to histology-defined instability and cardiovascular outcomes. ResultsT cell responses in unstable versus stable atherosclerosis were distinct. Unstable human plaques contained highly expanded, autoimmune-like CD8 T cells with markedly increased cytotoxic signatures, reduced exhaustion and distinct clonal repertoires compared to stable regions. Most plaque CD8 T cells exhibited a pronounced tissue-resident transcriptional program. Moreover, the transcriptional signature of these plaque resident T cells was distinct from multiple other human tissues. Autoimmune-like cytotoxic and tissue-resident CD8+ T cell responses were also evident in murine atherosclerosis, where restricting the activation of antigen-driven CD8+ T cells prevented plaque destabilisation. Importantly, analysis of carotid endarterectomy samples from >1000 patients identified that intraplaque cytotoxic CD8 T cell gene signatures strongly correlated with histological instability and predicted future strokes. ConclusionsIntegrated human, murine and clinical analyses demonstrate that autoimmune-like, cytotoxic CD8 T cell responses are central drivers of plaque instability and major cardiovascular events. Targeting pathogenic CD8 T cell responses may thus offer a compelling immunomodulatory strategy to stabilise plaques and reduce the risks of stroke and myocardial infarction. Graphical AbstractO_ST_ABSKey QuestionC_ST_ABSRupture of unstable atherosclerotic plaques is a typical cause of myocardial infarction and stroke. To understand the underlying cause and to prevent plaque rupture, we addressed the central hypothesis that autoimmune-like T cell responses drive plaque destabilisation and rupture. Key FindingsCD8+ T cells are clonally expanded with increased cytotoxic signatures in unstable versus stable plaques (mice and humans) and require antigen recognition to drive plaque instability. Cytotoxic CD8+ T cell signatures in excised plaques correlate with increased future cardiovascular events. Take Home MessageAutoimmune-like adaptive immune reactions, dominated by CD8+ T cells, are a major driver of plaque instability/rupture. Therefore, targeting pathogenic CD8 T cell responses offers a compelling immunomodulatory strategy to stabilise plaques and reduce the risk of myocardial infarction and stroke. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/720043v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@bd83dcorg.highwire.dtl.DTLVardef@1bee3borg.highwire.dtl.DTLVardef@1b56bc0org.highwire.dtl.DTLVardef@1b5176f_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Atherosclerosis
29 papers in training set
Top 0.1%
28.4%
2
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.3%
8.6%
3
Circulation
66 papers in training set
Top 0.5%
8.4%
4
Circulation Research
39 papers in training set
Top 0.1%
7.0%
50% of probability mass above
5
Nature Cardiovascular Research
28 papers in training set
Top 0.1%
6.5%
6
Cell Reports
1338 papers in training set
Top 14%
3.7%
7
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.1%
8
Journal of the American Heart Association
119 papers in training set
Top 2%
2.1%
9
Science Translational Medicine
111 papers in training set
Top 2%
1.9%
10
Cardiovascular Research
33 papers in training set
Top 0.5%
1.7%
11
BMC Medicine
163 papers in training set
Top 3%
1.7%
12
Nature Communications
4913 papers in training set
Top 51%
1.7%
13
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.7%
14
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.4%
15
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.3%
16
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
1.3%
17
Immunology
29 papers in training set
Top 0.7%
1.1%
18
Journal of Cerebral Blood Flow & Metabolism
43 papers in training set
Top 0.5%
0.9%
19
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
20
eLife
5422 papers in training set
Top 55%
0.8%
21
Arthritis & Rheumatology
33 papers in training set
Top 0.5%
0.8%
22
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%
23
Immunity
58 papers in training set
Top 5%
0.7%
24
eBioMedicine
130 papers in training set
Top 6%
0.5%
25
Frontiers in Immunology
586 papers in training set
Top 9%
0.5%
26
Frontiers in Neurology
91 papers in training set
Top 6%
0.5%